Fei Y J, Oner R, Bözkurt G, Gu L H, Altay C, Gurgey A, Fattoum S, Baysal E, Huisman T H
Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta 30912-2100.
Acta Haematol. 1992;88(2-3):82-5. doi: 10.1159/000204657.
We have identified 7 patients with Hb H disease as homozygotes for a mutation in the polyadenylation site (AATAAA-->AATAAG) and have compared their hematological data with those of Hb H patients having other types of alpha-thalassemia determinants. All 7 patients exhibited moderate anemia with microcytosis and hypochromia being similar to that observed in the other patients. Relatives with a heterozygosity for this mutation are borderline microcytic and hypochromic without a significant anemia but with a low in vitro alpha/beta chain synthesis ratio. Analyses of the hemoglobin components identified low levels of Hb A2 and Hb H that were comparable to those found in other patients with Hb H disease; the level of the zeta-chain was low (average 0.14%).
我们已鉴定出7例血红蛋白H病患者为多聚腺苷酸化位点突变(AATAAA→AATAAG)的纯合子,并将他们的血液学数据与具有其他类型α地中海贫血决定因素的血红蛋白H病患者的数据进行了比较。所有7例患者均表现为中度贫血,伴有小红细胞症和低色素血症,与其他患者观察到的情况相似。该突变杂合子的亲属有轻度小红细胞症和低色素血症,无明显贫血,但体外α/β链合成率较低。血红蛋白成分分析显示,血红蛋白A2和血红蛋白H水平较低,与其他血红蛋白H病患者的水平相当;ζ链水平较低(平均0.14%)。